S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Is This Stock On Your Radar (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
Is This Stock On Your Radar (Ad)
Can Cummins Power To A New High? 
ONSemi Is Marching Higher On Great Results
Is This Stock On Your Radar (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Here’s the Silver Lining with Snap Stock Earnings Collapse
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Is This Stock On Your Radar (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
Is This Stock On Your Radar (Ad)
Can Cummins Power To A New High? 
ONSemi Is Marching Higher On Great Results
Is This Stock On Your Radar (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Here’s the Silver Lining with Snap Stock Earnings Collapse
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Is This Stock On Your Radar (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
Is This Stock On Your Radar (Ad)
Can Cummins Power To A New High? 
ONSemi Is Marching Higher On Great Results
Is This Stock On Your Radar (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Here’s the Silver Lining with Snap Stock Earnings Collapse
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Is This Stock On Your Radar (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
Is This Stock On Your Radar (Ad)
Can Cummins Power To A New High? 
ONSemi Is Marching Higher On Great Results
Is This Stock On Your Radar (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Here’s the Silver Lining with Snap Stock Earnings Collapse
NASDAQ:LNTH

Lantheus - LNTH Stock Forecast, Price & News

$60.02
-0.78 (-1.28%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$59.14
$61.85
50-Day Range
$47.76
$62.08
52-Week Range
$25.97
$87.47
Volume
920,702 shs
Average Volume
885,389 shs
Market Capitalization
$4.13 billion
P/E Ratio
40.28
Dividend Yield
N/A
Price Target
$102.80

Lantheus MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
71.3% Upside
$102.80 Price Target
Short Interest
Healthy
5.12% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
0.68mentions of Lantheus in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$1.11 M Sold Last Quarter
Proj. Earnings Growth
11.05%
From $3.53 to $3.92 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.94 out of 5 stars

Medical Sector

34th out of 1,027 stocks

Diagnostic Substances Industry

1st out of 15 stocks

LNTH stock logo

About Lantheus (NASDAQ:LNTH) Stock

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and Puerto Rico, third-party distribution in Europe, Canada, Australia, Asia-Pacific, and Latin America, and the EXINI business in Sweden. The company was founded in 1956 and is headquartered in North Billerica, MA.

Receive LNTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lantheus and its competitors with MarketBeat's FREE daily newsletter.

LNTH Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery
Investors constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. But America hasn't produced any graphite since the 1950s. Now, a little-known exploration company has defined America's largest high-quality graphite deposit near Nome, Alaska.
See More Headlines
Receive LNTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lantheus and its competitors with MarketBeat's FREE daily newsletter.

LNTH Company Calendar

Last Earnings
11/04/2021
Today
2/07/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LNTH
Employees
612
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$102.80
High Stock Price Forecast
$120.00
Low Stock Price Forecast
$91.00
Forecasted Upside/Downside
+71.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-71,280,000.00
Pretax Margin
20.21%

Debt

Sales & Book Value

Annual Sales
$425.21 million
Cash Flow
$1.26 per share
Book Value
$6.86 per share

Miscellaneous

Free Float
67,731,000
Market Cap
$4.13 billion
Optionable
Optionable
Beta
0.79

Key Executives

  • Mary Anne HeinoMary Anne Heino
    President, Chief Executive Officer & Director
  • Paul BlanchfieldPaul Blanchfield
    Chief Operating Officer
  • Robert J. MarshallRobert J. Marshall
    Chief Financial Officer & Treasurer
  • Simon Robinson
    Senior VP-Research & Pharmaceutical Development
  • Iryna Teslenko
    Vice President-Clinical Development













LNTH Stock - Frequently Asked Questions

Should I buy or sell Lantheus stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lantheus in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LNTH shares.
View LNTH analyst ratings
or view top-rated stocks.

What is Lantheus' stock price forecast for 2023?

5 equities research analysts have issued 12-month price targets for Lantheus' stock. Their LNTH share price forecasts range from $91.00 to $120.00. On average, they expect the company's share price to reach $102.80 in the next year. This suggests a possible upside of 71.3% from the stock's current price.
View analysts price targets for LNTH
or view top-rated stocks among Wall Street analysts.

How have LNTH shares performed in 2023?

Lantheus' stock was trading at $50.96 at the start of the year. Since then, LNTH shares have increased by 17.8% and is now trading at $60.02.
View the best growth stocks for 2023 here
.

Are investors shorting Lantheus?

Lantheus saw a drop in short interest in the month of January. As of January 15th, there was short interest totaling 3,450,000 shares, a drop of 5.5% from the December 31st total of 3,650,000 shares. Based on an average daily volume of 1,130,000 shares, the short-interest ratio is presently 3.1 days. Currently, 5.1% of the company's shares are short sold.
View Lantheus' Short Interest
.

When is Lantheus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our LNTH earnings forecast
.

How were Lantheus' earnings last quarter?

Lantheus Holdings, Inc. (NASDAQ:LNTH) issued its quarterly earnings data on Thursday, November, 4th. The medical equipment provider reported $0.08 EPS for the quarter, topping the consensus estimate of $0.06 by $0.02. The medical equipment provider had revenue of $102.10 million for the quarter, compared to analyst estimates of $97.13 million. Lantheus had a net margin of 13.35% and a trailing twelve-month return on equity of 37.77%. The business's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period last year, the business posted $0.04 EPS.

What guidance has Lantheus issued on next quarter's earnings?

Lantheus updated its fourth quarter 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of $0.95-$0.98 for the period, compared to the consensus estimate of $0.86. The company issued revenue guidance of $243.00 million-$247.00 million, compared to the consensus revenue estimate of $238.01 million.

What is Mary Anne Heino's approval rating as Lantheus' CEO?

4 employees have rated Lantheus Chief Executive Officer Mary Anne Heino on Glassdoor.com. Mary Anne Heino has an approval rating of 51% among the company's employees. This puts Mary Anne Heino in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Lantheus own?
When did Lantheus IPO?

(LNTH) raised $75 million in an initial public offering on Thursday, June 25th 2015. The company issued 7,900,000 shares at $8.50-$10.50 per share. Citigroup, Jefferies, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

What is Lantheus' stock symbol?

Lantheus trades on the NASDAQ under the ticker symbol "LNTH."

Who are Lantheus' major shareholders?

Lantheus' stock is owned by many different retail and institutional investors. Top institutional investors include Reinhart Partners Inc. (0.84%), Emerald Advisers LLC (0.62%), Fisher Asset Management LLC (0.52%), Congress Asset Management Co. MA (0.50%), Emerald Mutual Fund Advisers Trust (0.49%) and Allspring Global Investments Holdings LLC (0.45%). Insiders that own company stock include Andrea Sabens, Brian A Markison, Carol Walker, Daniel Niedzwiecki, Etienne Montagut, Gerard Ber, Heinz Christoph Maeusli, John J Bolla, Julie Mchugh, Mary Anne Heino, Michael P Duffy, Michael P Duffy, Paul Blanchfield, Robert J Jr Marshall and Sam R Leno.
View institutional ownership trends
.

How do I buy shares of Lantheus?

Shares of LNTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lantheus' stock price today?

One share of LNTH stock can currently be purchased for approximately $60.02.

How much money does Lantheus make?

Lantheus (NASDAQ:LNTH) has a market capitalization of $4.13 billion and generates $425.21 million in revenue each year. The medical equipment provider earns $-71,280,000.00 in net income (profit) each year or $1.49 on an earnings per share basis.

How many employees does Lantheus have?

The company employs 612 workers across the globe.

How can I contact Lantheus?

Lantheus' mailing address is 331 TREBLE COVE ROAD, NORTH BILLERICA MA, 01862. The official website for the company is www.lantheus.com. The medical equipment provider can be reached via phone at (978) 671-8001, via email at ir@lantheus.com, or via fax at 978-671-8860.

This page (NASDAQ:LNTH) was last updated on 2/7/2023 by MarketBeat.com Staff